Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06501105 · ClinicalTrials.gov registry record
Performance of WOUNDCHEK Bacterial Status
A clinical trial of Wound Heal, sponsored by Woundchek Laboratories.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06501105: Recruiting study of Wound Heal, sponsored by Woundchek Laboratories.
NCT06501105 is a study of Wound Heal that is actively recruiting participants, run by Woundchek Laboratories. The registered enrollment target is 75 participants, below the 116-participant average among 23 other Wound Heal trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06501105, a study of Wound Heal, is actively recruiting participants, sponsored by Woundchek Laboratories.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) when the test result is used to inform treatment decisions.
Conditions Studied
Interventions
- DEVICE WOUNDCHEK Bacterial Status
Study Locations (1)
New York
- Northwell Health Comprehensive Wound Healing & Hyperbaric Center - Lake Success
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2024-12 |
What NCT06501105 shows while recruiting
NCT06501105 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 116-participant average among 23 other Wound Heal trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Wound Heal appearing as the primary indexed condition, and to 1 intervention - of which WOUNDCHEK Bacterial Status is the first listed.
NCT06501105 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06501105 about?
NCT06501105 is a clinical study titled "Performance of WOUNDCHEK Bacterial Status". The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) when the test result is used to inform treatment decisions.
What is the current status of trial NCT06501105?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-06-18. Estimated completion is 2024-12.
What conditions does trial NCT06501105 study?
This clinical trial studies the following conditions: Wound Heal.
What interventions are being tested in trial NCT06501105?
The interventions under investigation include: WOUNDCHEK Bacterial Status (DEVICE).
Who is sponsoring clinical trial NCT06501105?
This trial is sponsored by Woundchek Laboratories, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06501105 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Heal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06501105's enrollment target sits among peer trials
75 12th of 23 higher than 12 of 23 other Wound Heal trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Heal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Tissue Repair Gel in Venous Leg Ulcers in AU/US
RECRUITING · Phase 3
-
Dermabrasion in Mohs: Split-Scar Trial
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
EDX110 Randomized Control Trial for Treatment of DFUs
RECRUITING · NA
-
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI